BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 31151766)

  • 1. Postpartum profiling of microRNAs involved in pathogenesis of cardiovascular/cerebrovascular diseases in women exposed to pregnancy-related complications.
    Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L
    Int J Cardiol; 2019 Sep; 291():158-167. PubMed ID: 31151766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood.
    Hromadnikova I; Kotlabova K; Hympanova L; Krofta L
    Thromb Res; 2016 Jan; 137():126-140. PubMed ID: 26632513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and Cerebrovascular Disease Associated microRNAs Are Dysregulated in Placental Tissues Affected with Gestational Hypertension, Preeclampsia and Intrauterine Growth Restriction.
    Hromadnikova I; Kotlabova K; Hympanova L; Krofta L
    PLoS One; 2015; 10(9):e0138383. PubMed ID: 26394310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postnatal Expression Profile of microRNAs Associated with Cardiovascular and Cerebrovascular Diseases in Children at the Age of 3 to 11 Years in Relation to Previous Occurrence of Pregnancy-Related Complications.
    Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L; Sirc J
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes Mellitus and Cardiovascular Risk Assessment in Mothers with a History of Gestational Diabetes Mellitus Based on Postpartal Expression Profile of MicroRNAs Associated with Diabetes Mellitus and Cardiovascular and Cerebrovascular Diseases.
    Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of cardiovascular and cerebrovascular disease associated microRNA expression in umbilical cord blood in gestational hypertension, preeclampsia and fetal growth restriction.
    Hromadnikova I; Kotlabova K; Ivankova K; Vedmetskaya Y; Krofta L
    Int J Cardiol; 2017 Dec; 249():402-409. PubMed ID: 29121743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A History of Preterm Delivery Is Associated with Aberrant Postpartal MicroRNA Expression Profiles in Mothers with an Absence of Other Pregnancy-Related Complications.
    Hromadnikova I; Kotlabova K; Krofta L
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Vascular Endothelial Function in Young and Middle-Aged Women with Respect to a History of Pregnancy, Pregnancy-Related Complications, Classical Cardiovascular Risk Factors, and Epigenetics.
    Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First trimester prediction models for small-for- gestational age and fetal growth restricted fetuses without the presence of preeclampsia.
    Hromadnikova I; Kotlabova K; Krofta L
    Mol Cell Probes; 2023 Dec; 72():101941. PubMed ID: 37951512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Disease-Associated MicroRNA Dysregulation during the First Trimester of Gestation in Women with Chronic Hypertension and Normotensive Women Subsequently Developing Gestational Hypertension or Preeclampsia with or without Fetal Growth Restriction.
    Hromadnikova I; Kotlabova K; Krofta L
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Trimester Prediction of Preterm Delivery in the Absence of Other Pregnancy-Related Complications Using Cardiovascular-Disease Associated MicroRNA Biomarkers.
    Hromadnikova I; Kotlabova K; Krofta L
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-Trimester Screening for Fetal Growth Restriction and Small-for-Gestational-Age Pregnancies without Preeclampsia Using Cardiovascular Disease-Associated MicroRNA Biomarkers.
    Hromadnikova I; Kotlabova K; Krofta L
    Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs.
    Hromadnikova I; Dvorakova L; Kotlabova K; Krofta L
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Analysis in Children Born from Normal and Complicated Pregnancies-Cardiovascular Disease Associated microRNAs and the Incidence of Prehypertension/Hypertension, Overweight/Obesity, Valve Problems and Heart Defects.
    Hromadnikova I; Kotlabova K; Krofta L; Sirc J
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of plasma microRNA in preeclamptic patients at delivery and 1 year postpartum.
    Murphy MS; Casselman RC; Tayade C; Smith GN
    Am J Obstet Gynecol; 2015 Sep; 213(3):367.e1-9. PubMed ID: 25981845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications.
    Hromadnikova I; Kotlabova K; Ondrackova M; Pirkova P; Kestlerova A; Novotna V; Hympanova L; Krofta L
    DNA Cell Biol; 2015 Jun; 34(6):437-57. PubMed ID: 25825993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications.
    Hromadnikova I; Kotlabova K; Krofta L
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of miR-628-3p and miR-628-5p during the early pregnancy are increased in women who subsequently develop preeclampsia.
    Martinez-Fierro ML; Carrillo-Arriaga JG; Luevano M; Lugo-Trampe A; Delgado-Enciso I; Rodriguez-Sanchez IP; Garza-Veloz I
    Pregnancy Hypertens; 2019 Apr; 16():120-125. PubMed ID: 31056146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-Trimester Screening for Miscarriage or Stillbirth-Prediction Model Based on MicroRNA Biomarkers.
    Hromadnikova I; Kotlabova K; Krofta L
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential early biomarkers of preeclampsia.
    Timofeeva AV; Gusar VA; Kan NE; Prozorovskaya KN; Karapetyan AO; Bayev OR; Chagovets VV; Kliver SF; Iakovishina DY; Frankevich VE; Sukhikh GT
    Placenta; 2018 Jan; 61():61-71. PubMed ID: 29277273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.